期刊文献+

微血管密度测定在子宫内膜癌病变发展中的价值 被引量:1

The Value of the Measurement of Microvessel Density in the Development of Endometrial Carcinoma
下载PDF
导出
摘要 目的 探讨血管生成活性在子宫内膜癌发展中的价值。方法 采用Ⅷ因子相关抗原为标志物 ,以免疫组化技术对正常子宫内膜、不典型增生内膜 ,子宫内膜癌组织进行微血管密度 (MVD)测定。结果 ①正常组与内膜癌组比较 (P <0 .0 1) ,正常组与不典型增生组比较 (P <0 .0 5 ) ;从正常内膜、不典型增生到内膜癌组织内MVD逐渐增多 (P <0 .0 5 )。②内膜癌组织内MVD与肿瘤细胞分化程度有关 (P <0 .0 5 )。结论 临床采用MVD测定对子宫内膜增生病变发展和追随检查具有重要价值 ,同时MVD测定可作为判断子宫内膜癌预后的指标之一。 Objective To study the value of the activity of angiogenesis in the development of endometrial carcinoma.Methods To assaged the microvessel density(MVD) of normal endometrium,endometrial atypical hyperplasia and endometrial carcinoma by immunohisto chemical method,using the Faetor Ⅷ related antigen as the marker.Results ①There was a significant difference in MVD between the normal group and the cancer group (P<0.01).And also there was a significant difference in MVD between the normal group and the atypical hyperplasia group (P<0.05).The MVD was gradually increased from normal endometrium and atypical hyperplasia to endometrial carcinoma (P<0.05).②Intratumor microvessel density is associated with the differentiation of tumor (P<0.05). Conclusion The measurement of MVD is of great value in monitoring the development of endometrial hyperplasia.Meanwhile the measurement of MVD can be one of indications to predict the prognosis of endometrial carcinoma.
出处 《潍坊医学院学报》 2003年第5期327-328,共2页 Acta Academiae Medicinae Weifang
基金 山东省教育厅资助课题 (课题编号 :J98K60 )
关键词 子宫内膜癌 内膜增生 微血管密度 预后 Endometrial carcinoma Endometrial hyperplasia Microvessel density Prognosis
  • 相关文献

参考文献2

  • 1曹泽毅.中华妇产科学[M].北京:人民卫生出版社,1999.2129.
  • 2沈铿 郎景和.妇科肿瘤[M].北京:人民卫生出版社,2002.58.

共引文献3239

同被引文献17

  • 1赵瑾凤,郑建华,韩世愈,韩旭.肝细胞生长因子及其受体c-Met在子宫内膜癌中的表达[J].哈尔滨医科大学学报,2004,38(4):362-364. 被引量:2
  • 2杨娜,王月玲,韩水平.VEGF在子宫内膜癌组织中的表达和意义[J].现代肿瘤医学,2004,12(6):501-503. 被引量:4
  • 3唐良萏,肖琳.子宫内膜样癌组织中HGF/c-Met的表达及其与细胞增殖、血管生成的关系[J].现代妇产科进展,2005,14(2):111-114. 被引量:1
  • 4王巍,闫莉.子宫内膜癌组织中微血管密度表达的临床研究[J].徐州医学院学报,2006,26(3):251-255. 被引量:1
  • 5IWAZAWA T, SHIOZAKI H, DOKI Y, et al. Primary human fi-broblasts induce diverse tumor invasiveness: involvement of HGF as an important paracrine factor[ J]. Jpn J Cancer Res, 1996, 87 (11) : 1134 -1142.
  • 6BROWN J M, GIACCIA A J. The unique physiology of solid tumors : opportunities ( and problems ) for cancer therapy [ J ]. Cancer Res, 1998, 58(7) : 1408 - 1416.
  • 7BERGERS G, BENJAMIN L E. Tumorigenesis and the angiogenic switch[J]. Nat Rev Cancer, 2003, 3(6):401-410.
  • 8RAFII S, HEISSIG B, HATTORI K. Efficient mobilization and recruitment of marrow - derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors[ J]. Gene Ther, 2002, 9(10) : 631 -641.
  • 9GHASEMI M, EMADIAN O, NAGHSHVAR F, et al. Immuno- histochemical expression of vascular endothelial growth factor and its correlation with tumor grade in breast ductal carcinoma [ J ]. Acta Med, 2011, 49(12) : 776 -779.
  • 10PARTYKA R, GONCIARZ M, JALOWIECKI P, et al. VEGF and metalloproteinase 2 ( MMP 2 ) expression in gastric cancer tissue [J]. MedSciMonit, 2012, 18(4): 130 -134.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部